(Q33330518)

25 July 2017

1 reference

title

Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor (English)

1 reference

systemic lupus erythematosus

25 July 2017

1 reference

1 reference

1 reference

Hellmich B

1

1 reference

25 July 2017

Schnabel A

series ordinal

2

1 reference

25 July 2017

Gross WL

series ordinal

3

1 reference

25 July 2017

publication date

1 October 1999

1 reference

Seminars in Arthritis and Rheumatism

25 July 2017

published in

1 reference

25 July 2017

volume

29

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

82-99

1 reference

Hematologic aspects of systemic lupus erythematosus. Current concepts

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Autoimmune neutropenia in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Haematological manifestations of systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Selective inhibition of granulopoiesis with severe neutropenia in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Neutrophil chemotaxis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Phagocytic Function of Polymorphonuclear Leukocytes in Rheumatic Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Treatment of Felty's syndrome with low-dose oral methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Cyclosporine in Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Parenteral gold therapy in the Felty syndrome. Experience with 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Prospective evaluation of the chemiluminescence test for the detection of granulocyte antibodies: comparison with the granulocyte immunofluorescence test

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Anti-neutrophil antibodies of the immunoglobulin M class in autoimmune neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Lack of evidence for the presence of neutrophil autoantibodies in the serum of patients with Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Complement-activating antineutrophil antibody in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Bone marrow findings in lupus patients with pancytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Bone marrow findings in connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Granulopoiesis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Morphology of bone marrow in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Sequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Successful reversal of neutropenia in Felty's syndrome with recombinant granulocyte colony stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Treatment of the neutropenia of Felty syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

rhG-CSF resistant neutropenia in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Treatment of severe leukopenia with RHG-CSF in systemic lupus erythematosus treated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Plasmapheresis in Felty's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Felty's syndrome. A clinical and pathological survey of 21 patients and their response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Felty's syndrome: long-term follow-up after splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Clinical and Serologic Observations on 27 Patients with Felty's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Felty's syndrome. Clinical and serological analysis of 34 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Splenectomy for cytopenias associated with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Pathophysiology and treatment of severe chronic neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Hematopoietic growth factors for the treatment of severe chronic neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Sustained response in Felty's syndrome to prolonged administration of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Successful treatment of chronic wound infection in neutropenia and rheumatoid arthritis with filgrastim (rhG-GSF)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

GM-CSF in the treatment of Felty syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Felty's syndrome: favorable response to granulocyte-macrophage colony-stimulating factor in the acute phase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

CD4+ T cell-mediated leukopenia of Felty's syndrome successfully treated with granulocyte-colony-stimulating factor and methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Prolonged treatment with granulocyte colony-stimulating factor in a patient with Felty's syndrome and chronic renal failure from secondary amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

G-CSF improves granulocytopenia in Felty's syndrome without flare-up of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Long-term remission of neutropenia in Felty's syndrome after a short GM-CSF treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

GM-CSF and G-CSF in Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Combined therapy of G-CSF and prednisolone for neutropenia in a patient with Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

The use of granulocyte colony-stimulating factor in joint replacement surgery in a patient with Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

GM-CSF versus G-CSF in the treatment of infectious complication in Felty's syndrome--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Treatment of chronic leg ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Granulocyte colony-stimulating factor induction of improved leukocytopenia with inflammatory flare in a Felty's syndrome patient

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Effective simultaneous rhG-CSF and methylprednisolone "pulse" therapy in agranulocytosis associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Granulocyte-colony stimulating factor corrects granulocytopenia in Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Haematological study of healthy volunteers 5 years after G-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

The Felty syndrome and G-CSF-associated thrombocytopenia and severe anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Identification of a functional receptor for granulocyte colony-stimulating factor on platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Cutaneous vasculitis associated with granulocyte colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Drugs associated with vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Differential effects of granulocyte‐ and granulocyte‐macrophage colony‐stimulating factors (G‐ and GM‐CSF) on neutrophil adhesion in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Reversible thyroid dysfunction during treatment with GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

GM-CSF and accelerated hemolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Recombinant human granulocyte-macrophage colony-stimulating factor produces fever

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

Long-term outcome in Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980040-7

7 January 2021

10.1016/S0049-0172(99)80040-7

Identifiers

DOI

1 reference

release_y6qrjz566bbbpbm567ccgech4a

25 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y6qrjz566bbbpbm567ccgech4a

24 November 2022

mapped directly with Wikidata item

1 reference